Response to Gurevich and colleagues: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts

Spada, Marco;
2019-01-01

2019
20
1
2
Agalsidase alfa; Agalsidase beta; Enzyme replacement therapy; Fabry disease
Germain, Dominique P.; Falissard, Bruno; Hilz, Max J.; Spada, Marco; Wanner, Christoph; Elliott, Perry M.
File in questo prodotto:
File Dimensione Formato  
Response to Gurevich and colleagues The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease a systematic literature review by a European panel of experts..pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 346.04 kB
Formato Adobe PDF
346.04 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1985210
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact